Skip to content
Yasser Hazzaa

Yasser Hazzaa

Founder & Principal Consultant

Strategic Finance Partner and Board Advisor

Architecting financial discipline for biopharma inflection points. Empowering executive teams to navigate commercialization, financing, and portfolio decisions with institutional rigor and measurable outcomes.

Scroll to explore

Executive Credentials

Trusted Leader with Track Record

Bristol Myers SquibbMannKind Corporation

$17B

Planning Scope

Bristol Myers Squibb

~600%

Market Cap Growth

MannKind Corporation

20%+

Reporting Cycle Reduction

Dashboard automation impact

150+

Global FP&A Community

Bristol Myers Squibb

25+

Years Finance Leadership

Bristol Myers Squibb and MannKind Corporation

2

Board Positions

TesoRx Pharma and Lipac Oncology; clinical stage companies

Services

Strategic Finance Services

On desktop, hover each service to reveal executive context. On mobile, details are visible by default.

Capital Allocation and Runway Strategy

Prioritize portfolio investments with disciplined runway logic, milestone based decision frameworks, and clear board level tradeoffs.

Board Ready Reporting and Narrative Building

Translate operating performance into concise board narratives that align capital, risk, and forward strategy.

Fundraising and Diligence Readiness

Prepare investor data rooms, integrated model packs, and executive Q&A narratives that accelerate financing conversations.

CFO Consulting and Team Leadership

Establish executive finance cadence, elevate team execution, and strengthen governance without adding organizational drag.

CFO Consulting and Strategic Advisory

Guide leadership transitions and enterprise value decisions with public-company rigor tailored to growth-stage life sciences teams.

FP&A and Forecasting

Build decision ready planning, rolling forecast discipline, and driver based analysis for faster executive action.

Cash Runway and Working Capital Control

Strengthen liquidity visibility, improve working capital discipline, and protect operating flexibility across milestones.

Diligence, Integration, and Margin Protection

De risk transactions and protect margin through diligence frameworks, integration planning, and commercial controls.

Investor Relations and Capital Markets Advisory

Sharpen equity narrative, guidance readiness, and investor communications with institutional quality finance discipline.

Pre Commercial Launch Finance Readiness

Align pricing, payer assumptions, and launch economics into a finance framework leadership can execute with confidence.

Track Record

Outcomes That Speak

A career defined by delivering measurable financial transformation for global biopharmaceutical organizations.

~600%

Market Cap Growth

MannKind Corporation

VP Finance, 2017 to 2025

Partnered with Executive Leadership Team (ELT) to achieve 600% growth in enterprise value through rigorous FP&A and capital strategy during a transformative seven-year growth cycle.

FP&ACapital StrategyBoard Reporting

20%+

Reporting Cycle Reduction

MannKind Corporation

VP Finance

Optimized reporting workflows with Power BI automation; this reduced reporting cycle time by more than 20 percent and strengthened decision velocity.

Power BIDashboard AutomationProcess Improvement

150+

Global FP&A Community

Bristol Myers Squibb

FP&A COE Lead, 2015 to 2016

Built a global FP&A community driving process excellence and capability development across the organization.

Team DevelopmentGlobal LeadershipProcess Excellence

$17B

Planning Scope

Bristol Myers Squibb

Director Corporate FP&A, 2011 to 2015

Led Long-Term Financial Plan and served as Global Finance Lead for Virology, Neuroscience, and Immuno-science franchises.

Strategic PlanningFranchise LeadershipBoard Presentations
Contact

Let's build
something
exceptional

Strategic CFO leadership for biopharma at key inflection points: clinical milestones, commercialization, and financing. Board-ready reporting, capital allocation, and forecasting discipline grounded in Fortune 500 standards. Let's align your strategy to measurable value creation.

Book a Consultation

Fill out the form below to get started

Fields marked with * are required.